Clene Inc. (CLNN)

Official site

CONSUMER DEFENSIVE • PACKAGED FOODS • NASDAQ

$3.31

-0.01 (-0.15%)

Market Cap: $47.05M

Last updated: Oct 16, 2026 at 1:54 PM ET

Earnings

Performance (10Y)

Beat Rate

39%(9/23)

Avg Surprise

-14.43%

Upcoming Estimates

Period ending Sep 30, 2026

EPS Consensus$-0.47

Range$-0.49 - $-0.46

2 analysts

EPS RevisionsNo revisions (7d)

30d

EPS Estimate DriftChange to current

90d ago$-0.28-69.6%

60d ago$-0.28-69.6%

30d ago$-0.28-69.6%

7d ago$-0.28-69.6%

Current$-0.47

Revenue Consensus

$59200

Range$0 - $130000

5 analysts

Period ending Dec 31, 2026

EPS Consensus$-1.18

Range$-1.34 - $-1.02

2 analysts

Revenue Consensus

$107570

Range$-36830 - $258170

5 analysts

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2026Dec 26EST	-	$-1.18	$-1.34 - $-1.02	-	-	2	-	-
Sep 30, 2026Sep 26EST	-	$-0.47	$-0.49 - $-0.46	-	-	2	0 2 30d	-
Jun 30, 2026Jun 26 Reported Aug 14, 2026Reported Aug 14	$-0.60	$-0.37	$-0.41 - $-0.33	-62.16%	Miss	2	No revisions (30d)	+31.8%
Mar 31, 2026Mar 26 Reported May 14, 2026Reported May 14	$-0.24	N/A	-	+65.71%	Beat	2	0 1 30d	+52.0%
Dec 31, 2025Dec 25 Reported Mar 12, 2026Reported Mar 12	$-0.78	$-0.42	$-0.58 - $-0.26	-85.38%	Miss	2	1 1 30d	+42.9%
Sep 30, 2025Sep 25 Reported Nov 13, 2025Reported Nov 13	$-0.61	$-0.56	$-0.69 - $-0.36	-8.93%	Miss	3	1 0 30d	+45.0%
Jun 30, 2025Jun 25 Reported Aug 14, 2025Reported Aug 14	$-0.88	$-0.46	$-0.64 - $-0.28	-91.30%	Miss	2	0 1 30d	+32.3%
Mar 31, 2025Mar 25 Reported May 7, 2025Reported May 7	$-0.50	$-0.78	$-0.99 - $-0.49	+35.90%	Beat	5	1 0 30d	+67.3%
Dec 31, 2024Dec 24 Reported Mar 24, 2025Reported Mar 24	$-1.36	$-0.88	$-1.11 - $-0.42	-55.42%	Miss	5	1 2 30d	-2174.3%
Sep 30, 2024Sep 24 Reported Nov 13, 2024Reported Nov 13	$-1.11	$-1.29	$-1.51 - $-1.09	+13.95%	Beat	5	No revisions (30d)	+27.9%
Jun 30, 2024Jun 24 Reported Aug 7, 2024Reported Aug 7	$-1.30	$-1.42	$-1.60 - $-1.25	+8.45%	Beat	5	No revisions (30d)	+78.5%
Mar 31, 2024Mar 24 Reported May 8, 2024Reported May 8	$-1.53	$-1.47	$-1.48 - $-1.45	-4.08%	Miss	5	No revisions (30d)	-920.0%
Dec 31, 2023Dec 23 Reported Mar 13, 2024Reported Mar 13	$-0.06	$-0.07	$-0.08 - $-0.06	+14.29%	Beat	4	No revisions (30d)	+98.1%
Sep 30, 2023Sep 23 Reported Nov 7, 2023Reported Nov 7	$-1.54	$-1.53	$-1.56 - $-1.51	-0.65%	Miss	6	No revisions (30d)	+47.6%
Jun 30, 2023Jun 23 Reported Aug 14, 2023Reported Aug 14	$-6.06	$-2.13	$-2.15 - $-2.08	-184.51%	Miss	7	No revisions (30d)	-37.7%
Mar 31, 2023Mar 23 Reported May 12, 2023Reported May 12	$-0.15	$-0.14	$-0.19 - $-0.11	-7.14%	Miss	6	No revisions (30d)	+96.6%
Dec 31, 2022Dec 22 Reported Mar 13, 2023Reported Mar 13	$-3.15	$-2.48	$-2.53 - $-2.44	-27.02%	Miss	7	No revisions (30d)	-4600.0%
Sep 30, 2022Sep 22 Reported Nov 7, 2022Reported Nov 7	$-2.94	$-4.00	$-4.08 - $-3.97	+26.50%	Beat	7	No revisions (30d)	+8.4%
Jun 30, 2022Jun 22 Reported Aug 15, 2022Reported Aug 15	$-4.40	$-3.70	$-3.72 - $-3.68	-18.92%	Miss	7	No revisions (30d)	-2.3%
Mar 31, 2022Mar 22 Reported May 9, 2022Reported May 9	$-4.36	$-3.80	$-3.85 - $-3.78	-14.74%	Miss	6	No revisions (30d)	-11.2%
Dec 31, 2021Dec 21 Reported Mar 11, 2022Reported Mar 11	$0.07	N/A	-	+141.18%	Beat	5	1 0 30d	+600.0%
Sep 30, 2021Sep 21 Reported Nov 9, 2021Reported Nov 9	$-3.21	$-3.30	$-3.33 - $-3.22	+2.73%	Beat	5	No revisions (30d)	-4485.7%
Jun 30, 2021Jun 21 Reported Aug 10, 2021Reported Aug 10	$-4.30	$-2.20	$-2.25 - $-2.15	-95.45%	Miss	4	No revisions (30d)	-4200.0%
Mar 31, 2021Mar 21 Reported May 11, 2021Reported May 11	$-3.92	$-2.00	$-2.01 - $-1.99	-96.00%	Miss	2	No revisions (30d)	-5500.0%
Dec 31, 2020Dec 20 Reported Mar 29, 2021Reported Mar 29	$0.01	N/A	-	+111.11%	Beat	2	No revisions (30d)	+112.5%
Sep 30, 2020Sep 20 Reported Dec 18, 2020Reported Dec 18	$-0.07	N/A	-	N/A	Beat	-	-	-40.0%
Jun 30, 2020Jun 20 Reported Aug 3, 2020Reported Aug 3	$-0.10	N/A	-	N/A	Beat	-	-	-174.7%
Mar 31, 2020Mar 20 Reported May 14, 2020Reported May 14	$-0.07	N/A	-	N/A	Beat	-	-	-137.3%
Dec 31, 2019Dec 19 Reported Mar 30, 2020Reported Mar 30	$-0.08	N/A	-	N/A	Beat	-	-	-171.2%
Sep 30, 2019Sep 19 Reported Nov 15, 2019Reported Nov 15	$-0.05	N/A	-	N/A	Beat	-	-	+94.5%
Jun 30, 2019Jun 19 Reported Sep 30, 2019Reported Sep 30	$-0.04	N/A	-	N/A	Beat	-	-	-
Mar 31, 2019Mar 19 Reported Jun 29, 2019Reported Jun 29	$-0.03	N/A	-	N/A	Beat	-	-	-
Dec 31, 2018Dec 18 Reported Mar 30, 2019Reported Mar 30	$-0.03	N/A	-	N/A	Beat	-	-	-
Sep 30, 2018Sep 18 Reported Sep 30, 2018Reported Sep 30	$-0.90	N/A	-	N/A	Beat	-	-	-

Key Metrics

Valuation
P/E Ratio	-1.48	EV/EBITDA	N/A
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	0.00%	Operating Margin	-5941.00%
ROE	-1738.00%	ROIC	381.82%
Financial Health
Debt/Equity	-0.76x	Interest Coverage	-10.15x
Current Ratio	3.07x	Quick Ratio	3.07x
Trading Statistics
Beta	0.92	Avg Volume	107.08K
52-Week High	$13.50	52-Week Low	$3.23

Technical Indicators Dashboard

Moving Averages

SMA 10$3.72

SMA 20$3.98

SMA 50$4.11

SMA 200$5.29

EMA 10$3.65

EMA 20$3.83

EMA 50$4.22

EMA 200$5.14

MACD

Line: -0.21Signal: -0.14Hist: -0.07

ADX

ADX: 19.1+DI: 10.9-DI: 25.1

Aroon & PSAR

Aroon Up28.0

Aroon Down100.0

PSAR$4.05

Bollinger Bands

Upper Band$4.67

Lower Band$3.28

%B Position3493%(Upper)

Band Width0.02

RSI (14-Day)

Neutral

30.5

Momentum Oscillators

Stoch %K5.9

Stoch %D5.1

Williams %R-91.0

ROC (10d)-17.8%

Momentum-0.71

CCI (20d)-171.7

MFI (14d)9.0

Volatility Measures

ATR (14d)$0.29(8.9%)

StdDev (20d)0.35

Hist Vol50.3%(High)

Volume Flow

VWAP$3.31

OBV15.5M

AD Line6.3M

CMF (20d)-0.231

Volume Metrics

Avg Vol (20d)98.0K

Vol Ratio1.4x

VWMA (20d)$3.99

Pivot Points

R3$3.56

R2$3.48

R1$3.40

Pivot Point$3.31

S1$3.23

S2$3.15

S3$3.06

Advanced Oscillators

TSI-21.51

Ultimate Osc35.5

KST-69.08

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$90,000	$15,000	$77,000	$15,000	$27,000	$81,000	$91,000	$87,000	$91,000	$73,000	$170,000	$108,000
Cost of Revenue	$36,000	$355,000	$23,000	$0	$366,000	$20,000	$18,000	$18,000	$18,000	$16,000	$460,000	$12,000
Gross Profit	$54,000	$-340,000	$54,000	$15,000	$27,000	$61,000	$73,000	$69,000	$73,000	$57,000	$-290,000	$96,000

Operating Expenses	$5.40M	$1.72M	$7.30M	$5.66M	$5.89M	$4.14M	$8.73M	$7.88M	$7.46M	$9.29M	$9.64M	$9.64M
R&D	$3.47M	$329,000	$5.50M	$3.51M	$3.51M	$1.48M	$5.57M	$4.47M	$4.15M	$5.87M	$6.32M	$5.97M
SG&A	$1.93M	$1.75M	$1.81M	$2.15M	$2.19M	$2.66M	$2.70M	$3.41M	$3.23M	$3.10M	$3.28M	$3.18M
Operating Income	$-5,347,000	$-2,061,000	$-7,244,000	$-5,648,000	$-5,864,000	$-4,076,000	$-8,655,000	$-7,815,000	$-7,391,000	$-9,232,000	$-9,930,000	$-9,542,000

Interest Income	$55,000	$47,000	$40,000	$40,000	$62,000	$81,000	$110,000	$127,000	$269,000	$359,000	$458,000	$546,000
Interest Expense	$695,000	$791,000	$746,000	$649,000	$679,000	$608,000	$516,000	$1.02M	$1.28M	$1.24M	$1.20M	$1.19M
Income Before Tax	$-13,424,000	$-8,090,999	$-9,226,000	$-8,777,000	$-7,419,000	$-751,000	$-13,549,000	$-7,986,000	$-6,785,000	$-11,080,000	$-10,173,000	$-2,418,000
Income Tax Expense	$0	$0	$0	$0	$0	$0	$0	$0	$-1	$376,724	$12.09M	$-439,000

Net Income	$-13,424,000	$-8,090,999	$-9,226,000	$-8,777,000	$-7,419,000	$-751,000	$-13,549,000	$-7,986,000	$-6,785,000	$-11,080,000	$-10,173,000	$-2,418,000

EBITDA	$-4,994,000	$-6,944,999	$-8,120,000	$-7,763,000	$-6,374,000	$261,000	$-12,628,000	$-6,558,000	$-5,089,000	$-9,416,000	$-8,551,000	$-791,000
EBIT	$-5,347,000	$-7,299,999	$-8,480,000	$-8,128,000	$-6,740,000	$-143,000	$-13,033,000	$-6,964,000	$-5,503,000	$-9,836,000	$-8,973,000	$-1,230,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about CLNN

News

Two parties report shared voting power over 221,660 shares in Clene (CLNN).

Empery Asset Management, LP and Ryan M. Lane have reported shared voting and dispositive power over 221,660 common shares of Clene Inc. (CLNN)...

Stock Titan•Oct 13, 2026 1:11 PM ET10/13/26•Neutral

Clene Targets Q4 FDA Filing for ALS Drug CNM-Au8, Eyes Mid-2027 Decision

Clene plans to submit a New Drug Application to the FDA in Q4 for CNM-Au8, its investigational ALS treatment, with an anticipated FDA decision by mid-2027. Despite missing the primary endpoint in the HEALEY study...

TradingView•Oct 2, 2026 11:25 AM ET10/2/26•Somewhat-Bullish

Investors can meet Clene management in New York or online through Sept. 30

Clene Inc. (Nasdaq: CLNN) announced its participation in two investor conferences from September 29-30, 2026. Management will attend the 5th Annual ROTH Healthcare Opportunities Conference in New York and present...

Stock Titan•Sep 22, 2026 8:24 AM ET9/22/26•Neutral

Clene raises $4 million from insiders to fund operations

Clene Inc. (NASDAQ:CLNN) has successfully raised $4 million in gross proceeds through a registered direct offering of common stock to existing shareholders...

Investing.com•Sep 22, 2026 2:24 AM ET9/22/26•Somewhat-Bullish

A $4 million raise is expected to carry an ALS biotech past a potential FDA decision

Clene (CLNN) has successfully closed a $4 million registered direct offering of common stock, led by insiders and existing shareholders. This capital infusion is expected to fund the company's operations until mid-first...

Stock Titan•Sep 21, 2026 10:52 PM ET9/21/26•Somewhat-Bullish

CLNN Valuation and Fair Value

P/E: -1.5x
P/B: -1.7x

See GNG's fair value

CLNN Profitability: Margins, ROIC and FCF

Gross margin: -110.2%
Operating margin: -5941.0%
Net margin: 0.0%
ROIC: 381.8%
ROE: -1738.0%
FCF margin: -8103.5%

CLNN Competitors

Company	Ticker
Skillsoft Corp.	SKIL
Grove Collaborative Holdings, Inc.	GROV
The Hain Celestial Group Inc	HAIN
RYTHM, Inc.	RYM
Ihuman Inc	IH
17 Education Technology Group Inc	YQ
AMCON Distributing Company	DIT
Sunlands Technology Group	STG

Sector: Consumer Defensive

CLNN Bull Case vs Bear Case

Bull case

CLNN earns a 381.8% return on invested capital.
CLNN grew quarterly revenue 233.3% year over year.

Bear case

CLNN beat EPS estimates in 37.5% of its last 8 reported quarters.

CLNN Earnings: Beat Rate and Next Report

Beat rate: 3 of 8 quarters (37.5%)
Average surprise: -23.5%
EPS estimate (fiscal period ending Sep 30, 2026): $-0.47
Estimate revisions (30 days, fiscal period ending Sep 30, 2026): 0 up, 2 down

Frequently Asked Questions About CLNN

Does CLNN pay dividends?

Clene Inc. (CLNN) does not currently pay a regular dividend.

What is CLNN's market cap?

Clene Inc. (CLNN) has a market capitalization of $47.05M with a current stock price of $3.31.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In